Yourgene Health PLC
LSE:YGEN
Yourgene Health PLC
LSE:YGEN
Price:
0.515 GBX
Updated:
May 8, 2024
Yourgene Health PLC
Operating Income
|
Yourgene Health PLC
Operating Income Peer Comparison
Comparables:
SN
LIVN
LMDX
EKF
CREO
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Yourgene Health PLC
LSE:YGEN
|
Operating Income
-£5.7m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Operating Income
$763m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Operating Income
$89.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
0%
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Operating Income
-$225.1m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Operating Income
£4.9m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
7%
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Operating Income
-£30.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Yourgene Health PLC's Operating Income?
Operating Income
-5.7m
GBP
-5.7m
GBP
Based on the financial report for Sep 30, 2022, Yourgene Health PLC's Operating Income amounts to -5.7m GBP.
What is Yourgene Health PLC's Operating Income growth rate?
Operating Income CAGR 10Y
0%
0%
Over the last year, the Operating Income growth was -32%. The average annual Operating Income growth rates for Yourgene Health PLC have been -26% over the past three years , 4% over the past five years .
You don't have any saved screeners yet
